Correction: Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
[This corrects the article DOI: 10.3389/fphar.2023.1187066.].
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
[This corrects the article DOI: 10.3389/fphar.2023.1187066.].
Post-transplant cyclophosphamide (PTCy) is widely used for graft-versus-host disease (GvHD) prophylaxis in haploidentical hematopoietic cell transplantation. However, the kinetics of early immune reconstitution in real-world, heterogeneous cohorts, and their relationship with early outcomes, remain incompletely def...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.